Gilead Sciences Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
04-04
吉利德科学-0.15%盘后

DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Gilead Sciences Inc. $(GILD)$ slid 4.57% to $107.25 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 5.97% to 5,074.08 and Dow Jones Industrial Average falling 5.50% to 38,314.86.

The stock's fall snapped a two-day winning streak.

Gilead Sciences Inc. closed 10.60% below its 52-week high of $119.96, which the company reached on March 10th.

The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 4.12% to $153.24, Pfizer Inc. $(PFE)$ fell 5.43% to $22.97, and Abbott Laboratories $(ABT)$ fell 5.46% to $124.44.

Trading volume (12.8 M) eclipsed its 50-day average volume of 9.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled April 4, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

April 04, 2025 16:35 ET (20:35 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

no data

没有相关数据

如果下载按钮点击无跳转,请点击右上角菜单选择 “在浏览器打开”